Biocon Archives - Page 6 of 13 - Express Pharma

Biocon presents key Insights into clinical study that enabled DCGI approval of Itolizumab

Biocon to launch drug for COVID-19 patients; priced at Rs 8,000 per vial

Biocon and Mylan receive US FDA approval for Semglee, an insulin glargine injection

Kiran Mazumdar-Shaw awarded World Entrepreneur of the Year 2020 by EY

Seven success stories of LSSSDC’s partnerships to fight COVID-19

Biocon’s partner Mylan receives favourable ruling from US PTAB on Sanofi’s four device patents for Lantus SoloSTAR

Pharma leaders, policy makers discuss COVID-19 impact, way forward for industry

Biocon Biologics gets DCGI approval for emergency use of CytoSorb to treat critical COVID-19 patients

Biocon Biologics receives EU GMP Certification for multiple Biosimilars manufacturing facilities in Bengaluru

Biocon registers a 42 per cent dip in profits for Q4